Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

540
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
540
Drug Therapy01:28

Drug Therapy

69
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
69
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed <i>FLT3</i>-ITD-negative acute myeloid leukemia.

Future oncology (London, England)·2026
Same author

Genomic landscape of acute myeloid leukemia in adolescents and young adults.

Leukemia·2026
Same author

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Blood cancer journal·2026
Same author

Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

Acta haematologica·2026
Same author

Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

Blood·2026
Same author

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Leukemia·2026

相关实验视频

Updated: Jul 20, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K

洗钱性白血病整合疗法:时间问题

Adrian-Manuel Reimann1, Enrico Schalk2, Felix Jost1,3

  • 1Department of Mathematics, Otto von Guericke University (OVGU), Magdeburg, Germany.

Journal of cancer research and clinical oncology
|August 3, 2023
PubMed
概括

在1-3天 (AC-123) 服用细胞氨基酸会缩短急性髓性白血病 (AML) 患者白细胞恢复时间. 这种策略可以降低感染风险而不增加白血病爆发,支持AC-123加G-CSF作为标准治疗.

关键词:
急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.化疗 化疗是一种化学疗法.数字双胞胎 数字双胞胎 数字双胞胎数学建模的数学建模骨髓抑制是一种骨髓抑制.中性发育不良症是如何发生的

更多相关视频

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory
08:08

Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory

Published on: June 18, 2014

27.1K

相关实验视频

Last Updated: Jul 20, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory
08:08

Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory

Published on: June 18, 2014

27.1K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 严重的中性质缺血是接受治疗的急性髓性白血病 (AML) 患者死亡的主要原因.
  • 在AML治疗中,新的策略对于减轻中性质衰竭的严重程度和持续时间至关重要.

研究的目的:

  • 在AML整合疗法中比较细胞arabine (AC-123和AC-135) 给药方案的疗效.
  • 为了评估不同类型的cytarabine剂量,G-CSF剂量和周期长度对中性质衰竭恢复的影响.

主要方法:

  • 使用数字双胞胎虚拟队列对334个治疗计划进行分析.
  • 模拟了超过32565个整合周期,比较了AC-123和AC-135方案.
  • 评估白细胞 (WBC) 恢复时间和白血病爆发数.

主要成果:

  • 与AC-135相比,AC-123在99.6%的模拟周期中显著减少了WBC恢复时间,平均为3.5天,与AC-135相比.
  • 在94.2%的循环中,AC-123疗法显示出较少或相同数量的白血病爆发.
  • 这些发现适用于各种细胞胺剂量,G-CSF使用和周期长度.

结论:

  • 与G-CSF结合的AC-123时间表得到了AML整合的数值研究的支持.
  • 这种方法可以有效地减少中性衰竭的持续时间,从而降低危及生命的感染风险.
  • AC-123加G-CSF代表了传统的AML整合治疗的有希望的标准.